• Home
  • News
  • Trial Innovation Network COVID-19 Update

Trial Innovation Network COVID-19 Update

The Trial Innovation Centers (TICs) and Recruitment Innovation Center (RIC) remain operational during the ongoing COVID-19 pandemic. Patients still need access to clinical trials and studies that may benefit them. Helping researchers plan these future trials is a Trial Innovation Network (TIN) priority. CTSA Institutions have implemented guidelines to protect research participants, research personnel, and the larger communities from risk of infection from COVID-19.

CTSA investigators may find helpful information on the CLIC Website and Discussion Forums here: CTSA Program and Response to COVID-19 Discussion Forum.

TIN offers investigators the opportunity to request consultations and resources for multicenter clinical trials and studies. These are designed to help investigators, for example, develop proposals into protocols, enhance study operations, or improve recruitment and retention. Some consultations developed into clinical protocols may be implemented in the Network and within the CTSA Program.

Submit Your Proposal

View news related to policies and regulations

Have news or an announcement to share? Contact Daniel Nuttall at daniel_nuttall@med.unc.edu

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

NC TraCS Institute logo vertical

In partnership with:

Contact Us

Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

This email address is being protected from spambots. You need JavaScript enabled to view it.


Cite Us

© 2008-2020 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact